JY
NBP

Jeff Yass’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Jeff Yass’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.7K Buy
28,539
+15,722
+123% +$32.1K ﹤0.01% 12791
2026
Q1 		$31.5K Sell
12,817
-34,662
-73% -$116K ﹤0.01% 12753
2025
Q4 		$189K Sell
47,479
-6,470
-12% -$28.6K ﹤0.01% 10942
2025
Q3 		$204K Buy
53,949
+16,412
+44% +$55.7K ﹤0.01% 10951
2025
Q2 		$90.8K Buy
+37,537
New +$50.9K ﹤0.01% 11848
2024
Q4 		– Sell
-13,351
Closed -$16.6K – 12668
2024
Q3 		$16.6K Sell
13,351
-17,715
-57% -$22.2K ﹤0.01% 11659
2024
Q2 		$51.9K Buy
+31,066
New +$55.5K ﹤0.01% 11399
2024
Q1 		– Sell
-29,365
Closed -$55.8K – 12704
2023
Q4 		$55.8K Sell
29,365
-20,804
-41% -$31.1K ﹤0.01% 11672
2023
Q3 		$66.2K Buy
+50,169
New +$110K ﹤0.01% 11159
2022
Q4 		– Sell
-34,160
Closed -$129K – 12993
2022
Q3 		$137K Buy
34,160
+17,325
+103% +$131K ﹤0.01% 11363
2022
Q2 		$190K Sell
16,835
-313
-2% -$3.75K ﹤0.01% 10709
2022
Q1 		$278K Buy
17,148
+12,354
+258% +$317K ﹤0.01% 10457
2021
Q4 		$227K Buy
4,794
+1,308
+38% +$78.5K ﹤0.01% 11177
2021
Q3 		$253K Sell
3,486
-7,499
-68% -$542K ﹤0.01% 10987
2021
Q2 		$922K Buy
+10,985
New +$725K ﹤0.01% 7992

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jeff Yass's NBP Position: Q2 2026 in Review

Jeff Yass increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 123% in Q2 2026, buying an estimated $32.1K and bringing the position to 28,539 shares worth $55.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12791.

Jeff Yass first reported a position in NBP in Q2 2021 and has held it in 15 quarters since. The position peaked at $922K in Q2 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Jeff Yass held 28,539 shares of NovaBridge Biosciences American Depositary Shares worth $55.7K as of Q2 2026.
  • Jeff Yass bought 15,722 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $32.1K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12791 holding.
  • Jeff Yass first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 15 quarters since.
  • Jeff Yass's NovaBridge Biosciences American Depositary Shares position peaked at $922K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.